Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pattern-recognition receptors (PRRs) and innate immune sensors are a diverse group of proteins, including Toll-like receptors (TLRs) and NOD-like receptors (NLRs), that detect pathogen-associated or damage-associated molecular patterns (Janeway and Medzhitov, 2002). In the context of aluminum adjuvants, these sensors—most notably the NLRP3 inflammasome—are activated by the crystalline structure of the adjuvant or by endogenous signals like uric acid and DNA released from stressed cells (Eisenbarth et al., 2008; Kool et al., 2008). This activation triggers a cascade of inflammatory signaling that enhances the body's immune response to co-administered antigens by promoting the maturation of cytokines like IL-1β and IL-18 (Li et al., 2008). While essential for vaccine efficacy, over-activation or chronic persistence of these complexes can lead to localized inflammation, granulomas, or rare systemic autoimmune reactions (Shoenfeld and Agmon-Levin, 2011). Understanding these sensors is crucial for designing safer and more effective vaccine delivery systems that balance immunogenicity with safety.
Aluminum adjuvants activate the innate immune system by inducing the release of damage-associated molecular patterns (DAMPs) and directly stimulating the NLRP3 inflammasome, which leads to the maturation of IL-1β and IL-18 and enhances the adaptive immune response to antigens (Eisenbarth et al., 2008; Kool et al., 2008).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pattern-recognition receptors and innate immune sensors (PRRs).